08:30-08:50 Welcome from the city of Marseille, Prof. J.F. Mattéi | * |
08:30-09:30 Applied virology, Dr. E. Gould, VIZIER (UK) |  |
09:30-10:30 Respiratory Viruses session [Chairman J. Mesters, VIZIER (G)] |
- 09:30- 09:50 Potential therapeutic targets for Human Coronaviruses, J. Ziebuhr, Univ Belfast (UK)
| * |
| 09:50- 10:10 Development of Antivirals against RSV, P. Najarro, Arrow Therapeutics Ltd (UK) | * |
| 10:10- 10:30 Resistance of influenza virus to antiviral drugs, B. Lina, VIRGIL (F) | * |
| |
10:30-11:00 Coffee Break |
| |
11:00-12:20 Hemorrhagic Fevers session [Chairman H. Norder, VIZIER (S)] |
| 11:00-11:20 Epidemiology of hemorrhagic fevers, R. Charrel, VIZIER (F) | * |
| 11:20-11:40 Molecular mecanisms of protein expression of Arenaviruses, S. Gunther, BNInstitute (G) | * |
| 11:40-12:20 Dengue Antiviral drugs: status and outlook, S. Vasudevan, Novartis (Sing) | * |
| |
12:20-13:30 Lunch-cocktail around the posters and exhibitors. (13:00-13:30 Press conference) |
| |
13:30-14:00 From viral genomes to antivirals drugs, P. Kolar (European Commission) | * |
| |
14:00-16:00 Hepatitis session [Chairman W. Spaan, VIZIER (ND)] |
| 14:00- 14:20 Epidemiology of Hepatitis, H. Norder, VIZIER (S) | * |
| 14:20- 14:40 In vitro hepatitis C virus replication mecanisms, R. Bartenschlager, Med Univ Heidelberg (G) |  |
| 14:40- 15:20 Hepatitis C virus polymerase inhibitors, R. de Francesco, Merck (I) |  |
| 15:20- 16:00 Hepatitis C virus protease inhibitors, O. Lenz, Tibotec (B) | * |
|
|
16:00-16:30 Coffee Break
|
| |
16:30-17:30 Emerging Viral Diseases session [Chairman X. de Lamballerie, VIZIER (F)] |
- 16:30-16:50 Molecular mecanisms of pathogenicity and interspecies transmission of Avian Influenza Virus, H. Klenk, Marburg Inst (G)
|  |
| 16:50-17:10 Epidemiology of Chikungunya viral disease, A. Flahaut, Ecole HESP (F) |  |
| 17:10-17:30 Worldwide hot spots for emerging diseases/environmental determinants, J. Carver, ICAV consortium coordinator (Can) | * |
17:30-17:45 Concluding remarks by Dr Bruno Canard (VIZIER project Coordinator) |